Earnings History Data for Relay Therapeutics, Inc. (RLAY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Relay Therapeutics, Inc.

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-02-2024	AH		RLAY	Relay Therapeutics, Inc.	1,340	-0.67	-0.71	-0.56		9.95	-0.62 (-5.87%)	10.89	0.32 (3.03%)	5.95 - 19.54	2,163,497	1,330,000	516

02-11-2023	PM		RLAY	Relay Therapeutics, Inc.	806.08	-0.54	-0.83	-0.76	Relay Therapeutics GAAP EPS of -$0.54, revenue of $25.2M [11/3/2023 1:07 AM]	7.51	0.11 (1.55%)	8.18	0.78 (10.54%)	5.95 - 23.18	1,521,504	1,260,000	4,228
Relay Therapeutics GAAP EPS of -$0.54, revenue of $25.2M [11/3/2023 1:07 AM]
08-08-2023	AH		RLAY	Relay Therapeutics, Inc.	1,370	-0.81	-0.78	-0.71	Relay Therapeutics GAAP EPS of -$0.81 beats by $0.01, revenue of $0.12M misses by $0.59M [8/8/2023 4:32 PM]	11.14	-0.03 (-0.22%)	11.17	0.0 (0.00%)	9.67 - 33.06	858,139	850,000	15,075
Relay Therapeutics GAAP EPS of -$0.81 beats by $0.01, revenue of $0.12M misses by $0.59M [8/8/2023 4:32 PM]
04-05-2023	AH	4:05 PM ET (May 4)	RLAY	Relay Therapeutics, Inc.	1,270	-0.78	-0.70	-0.61	Relay Therapeutics GAAP EPS of -$0.78 misses by $0.09, revenue of $0.22M beats by $0.06M [5/4/2023 6:07 PM]	11.25	0.03 (0.27%)	10.71	-0.51 (-4.55%)	10.40 - 33.06	1,410,009	1,560,000	826
Relay Therapeutics GAAP EPS of -$0.78 misses by $0.09, revenue of $0.22M beats by $0.06M [5/4/2023 6:07 PM]
23-02-2023	AH	4:05 PM ET (Feb 23)	RLAY	Relay Therapeutics, Inc.	2,230	-0.56	-0.68	0.36	Relay Therapeutics GAAP EPS of -$0.56 beats by $0.14, revenue of $0.25M beats by $0.08M [2/23/2023 4:33 PM]	17.02	-0.41 (-2.35%)	17.43	0.0 (0.00%)	12.65 - 35.36	700,016	980,000	19,164
Relay Therapeutics GAAP EPS of -$0.56 beats by $0.14, revenue of $0.25M beats by $0.08M [2/23/2023 4:33 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	RLAY	Relay Therapeutics, Inc.	2,700	-0.76	-0.71	-0.66		20.53	-0.41 (-1.96%)	20.84	-0.10 (-0.48%)	12.65 - 37.52	604,526	640,000	100

04-08-2022	AH	4:05 PM ET (Aug 4)	RLAY	Relay Therapeutics, Inc.	2,300	-0.71	-0.62	-2.10	Relay Therapeutics GAAP EPS of -$0.71, revenue of $0.37M [8/4/2022 4:49 PM]	19.73	0.57 (2.97%)	19.73	0.0 (0.00%)	12.65 - 38.15	1,581,530	720,000	3,276
Relay Therapeutics GAAP EPS of -$0.71, revenue of $0.37M [8/4/2022 4:49 PM] Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights [Aug-04-22 04:05PM]
05-05-2022	AH	4:05 PM ET (May 5)	RLAY	Relay Therapeutics, Inc.	2,680	-0.61	-0.63	-0.47	Relay Therapeutics GAAP EPS of -$0.57 beats by $0.05, revenue of $0.42M [5/5/2022 4:52 PM]	20.63	-2.67 (-11.46%)	20.63	0.0 (0.00%)	19.05 - 38.60	2,212,322	610,000	325
Relay Therapeutics GAAP EPS of -$0.57 beats by $0.05, revenue of $0.42M [5/5/2022 4:52 PM] Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights [May-05-22 04:05PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	RLAY	Relay Therapeutics, Inc.	2,280	0.36	-0.60	0.00	Relay Therapeutics GAAP EPS of -$3.82, revenue of $3.03M [2/24/2022 4:45 PM]	22.37	0.67 (3.09%)	21.70	0.0 (0.00%)	19.05 - 45.86	376,885	610,000	21,017
Relay Therapeutics GAAP EPS of -$3.82, revenue of $3.03M [2/24/2022 4:45 PM] Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights [Feb-24-22 04:05PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	RLAY	Relay Therapeutics, Inc.	3,760	-0.66	-0.65	0.00	Relay Therapeutics EPS misses by $0.01, beats on revenue [11/10/2021 4:52 PM]	35.62	1.88 (5.56%)	33.74	0.0 (0.00%)	25.72 - 64.37	674,760	580,000	2,939
Relay Therapeutics EPS misses by $0.01, beats on revenue [11/10/2021 4:52 PM] Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights [Nov-10-21 04:05PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	RLAY	Relay Therapeutics, Inc.	3,040	-2.10	-0.48	-6.06	Relay Therapeutics EPS misses by $1.64, misses on revenue [8/12/2021 4:35 PM]	33.06	-0.45 (-1.36%)	33.52	0.0 (0.00%)	26.44 - 64.37	1,757,467	390,000	42,811
Relay Therapeutics EPS misses by $1.64, misses on revenue [8/12/2021 4:35 PM] Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results [Aug-12-21 04:05PM]